LIFECORE BIOMEDICAL, INC. Shareholders' Equity
LIFECORE BIOMEDICAL, INC. (LFCR) had Shareholders' Equity of -$34.09 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent -$34.09M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$28.44M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$14.20M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$10.54M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$34.09M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | -$28.44M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | -$14.20M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | -$10.54M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$861.00K 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $1.34M 10-Q · filed 2026-08-05 | |
| 2025-02-23 | $2.22M 10-Q · filed 2026-08-05 | $2.23M 10-Q · filed 2025-04-03 |
| 2024-11-24 | $15.45M 10-Q · filed 2026-08-05 | |
| 2024-08-25 | -$3.94M 10-Q · filed 2025-11-06 | -$3.94M 10-Q · filed 2024-10-04 |
| 2024-05-26 | $11.31M 10-KT · filed 2026-03-16 | |
| 2024-02-25 | $17.69M 10-Q · filed 2025-04-03 | |
| 2023-11-26 | $1.42M 10-Q · filed 2025-04-03 | |
| 2023-08-27 | -$13.56M 10-Q · filed 2025-01-02 | |
| 2023-05-28 | -$4.23M 10-KT · filed 2026-03-16 | |
| 2023-02-26 | $35.02M 10-Q · filed 2024-08-09 | $34.21M 10-Q · filed 2023-06-02 |
| 2022-11-27 | $71.14M 10-Q · filed 2024-08-09 | $74.17M 10-Q · filed 2023-03-16 |
| 2022-08-28 | $77.88M 10-Q · filed 2024-08-09 | $96.90M 10-Q · filed 2022-10-07 |
| 2022-05-29 | $87.82M 10-K · filed 2024-08-26 | $107.94M 10-K · filed 2022-09-14 |
| 2022-02-27 | $142.56M 10-K · filed 2024-03-20 | $144.07M 10-Q · filed 2022-04-07 |
| 2021-11-28 | $155.42M 10-K · filed 2024-03-20 | $156.20M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $193.12M 10-K · filed 2024-03-20 | $193.87M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $201.95M 10-K · filed 2024-08-26 | $202.78M 10-K · filed 2021-07-29 |
| 2021-02-28 | $202.20M 10-K · filed 2024-03-20 | $204.62M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $208.00M 10-K · filed 2024-03-20 | $208.94M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $218.54M 10-K · filed 2024-03-20 | $221.16M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $229.84M 10-K · filed 2024-03-20 | $231.04M 10-K · filed 2020-08-14 |
| 2020-02-23 | $247.67M 10-Q · filed 2021-04-08 | |
| 2019-11-24 | $259.08M 10-Q · filed 2021-04-08 | |
| 2019-08-25 | $264.95M 10-Q · filed 2021-04-08 | |
| 2019-05-26 | $270.14M 10-K/A · filed 2023-03-16 | |
| 2019-02-24 | $270.06M 10-Q · filed 2020-04-03 | |
| 2018-11-25 | $253.57M 10-Q · filed 2020-04-03 | |
| 2018-08-26 | $253.38M 10-Q · filed 2020-04-03 | |
| 2018-05-27 | $252.56M 10-K · filed 2021-07-29 | |
| 2018-02-25 | $248.63M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $231.19M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $229.56M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $226.61M 10-K · filed 2018-08-09 | |
| 2017-02-26 | $222.61M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $218.01M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $215.30M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $210.73M 10-K/A · filed 2018-03-15 | |
| 2016-02-28 | $205.06M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $225.15M 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $222.30M 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $218.43M 10-K · filed 2016-08-01 | |
| 2015-03-01 | $213.88M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $209.52M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $205.77M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $203.07M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $198.02M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $188.67M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $183.69M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $178.69M 10-K · filed 2014-08-01 | |
| 2013-02-24 | $173.02M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $166.11M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $155.11M 10-Q/A · filed 2013-01-02 | $153.29M 10-Q · filed 2012-10-03 |
| 2012-05-27 | $149.74M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $147.91M 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $140.76M 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $139.53M 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $136.06M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |